Detalles de la búsqueda
1.
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
Dig Dis Sci
; 69(2): 355-359, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112840
2.
Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary Center.
Dig Dis Sci
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811503
3.
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
Dig Dis Sci
; 69(2): 579-587, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087126
4.
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
Clin Gastroenterol Hepatol
; 21(7): 1913-1923.e2, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898598
5.
Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device.
Inflamm Bowel Dis
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520737
6.
Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes.
J Crohns Colitis
; 2023 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37879626
7.
Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project.
Crohns Colitis 360
; 4(4): otac042, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36778515
Resultados
1 -
7
de 7
1
Próxima >
>>